Li Miaomiao, Chen Xuan, Hu Shuang, Wang Runqin, Peng Xiaoli, Bai Xiaohong
School of Pharmacy, Shanxi Medical University, Taiyuan 030001, China.
School of Pharmacy, Shanxi Medical University, Taiyuan 030001, China.
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jan 1;1072:355-361. doi: 10.1016/j.jchromb.2017.11.046. Epub 2017 Dec 2.
Oil-in-salt hollow fiber liquid phase microextraction coupled with high performance liquid chromatography ultraviolet detection (HPLC-UV) was developed for determination of the blood concentrations of the main active compounds, hesperidin, honokiol, shikonin, magnolol, emodin and β,β'-dimethylacrylshikonin, after oral administration of Zi-Cao-Cheng-Qi decoction (ZCCQD) and their total plasma protein binding rates. In the procedure, a hollow fiber segment was immersed in organic solvent to fill the solvent in the fiber lumen and wall pore, and then the fiber was immersed into sodium chloride solution to cover a thin salt membrane on the fiber wall pore filling organic solvent. Various factors affecting the procedure, such as extraction solvent, sample phase pH, stirring rate, extraction time, NaCl concentration and fiber immersion time in the NaCl solution, were optimized. Under the optimum conditions, good linearities (r≥0.9905), low limits of detection (0.7-2.5ng/mL) or quantitation (1.2-12ng/mL), satisfactory precision (2.6%-12.8%) and accuracy (81.0%-114.2%) of this method, were observed. The results showed that, after oral administration of a 25g/kg dose, (1) the blood concentrations (at 0.5h) of hesperidin, honokiol, shikonin, magnolol, emodin and β,β'-dimethylacrylshikonin were 0.45, 0.40, 0.48, 0.74, 0.11 and 1.11μg/mL, respectively; (2) the total plasma protein binding rates of the six active compounds were 42.0% (hesperidin), 71.8% (honokiol), 64.6% (shikonin), 77.7% (magnolol), 75.3% (emodin) and 75.7% (β,β'-dimethylacrylshikonin), respectively. The proposed procedure coupled with HPLC shows obvious advantages, such as low solvent consumption, simple operation, high sensitivity and strong purifying and can be used for the determination of both the blood concentrations and total plasma protein binding rates of active compounds in traditional Chinese medicine.
建立了盐包油中空纤维液相微萃取结合高效液相色谱紫外检测法(HPLC-UV),用于测定口服紫草承气汤(ZCCQD)后主要活性成分橙皮苷、厚朴酚、紫草素、厚朴碱、大黄素和β,β'-二甲基丙烯酰紫草素的血药浓度及其血浆蛋白结合率。在该方法中,将一段中空纤维浸入有机溶剂中,使溶剂填充在纤维内腔和壁孔中,然后将纤维浸入氯化钠溶液中,在填充有机溶剂的纤维壁孔上覆盖一层薄盐膜。对影响该方法的各种因素,如萃取溶剂、样品相pH值、搅拌速率、萃取时间、氯化钠浓度和纤维在氯化钠溶液中的浸泡时间进行了优化。在最佳条件下,该方法具有良好的线性关系(r≥0.9905)、较低的检测限(0.7-2.5ng/mL)或定量限(1.2-12ng/mL)、令人满意的精密度(2.6%-12.8%)和准确度(81.0%-114.2%)。结果表明,口服25g/kg剂量后,(1)橙皮苷、厚朴酚、紫草素、厚朴碱、大黄素和β,β'-二甲基丙烯酰紫草素在0.5h时的血药浓度分别为0.45、0.40、0.48、0.74、0.11和1.11μg/mL;(2)这6种活性成分的血浆蛋白结合率分别为42.0%(橙皮苷)、71.8%(厚朴酚)、64.6%(紫草素)、77.7%(厚朴碱)、75.3%(大黄素)和75.7%(β,β'-二甲基丙烯酰紫草素)。所提出的结合HPLC的方法具有明显优势,如溶剂消耗低、操作简单、灵敏度高、净化能力强,可用于测定中药活性成分的血药浓度和血浆蛋白结合率。